Showing results (1-10 of 219) with videos related to
Sort By:
Pageof 22
American Journal of Clinical Dermatology|February 2, 2019
KIT as an Oncogenic Driver in Melanoma: An Update on Clinical DevelopmentDa Meng, Richard D CarvajalExpert Opinion on Biological Therapy|February 21, 2013
Anti-programmed death-1 and anti-programmed death-ligand 1 antibodies in cancer therapyOmid Hamid, Richard D CarvajalCurrent Oncology Reports|July 30, 2020
Novel Approaches to the Systemic Management of Uveal MelanomaShaheer Khan, Richard D CarvajalCurrent Oncology Reports|May 17, 2017
Immunotherapy for the Treatment of Uveal Melanoma: Current Status and Emerging TherapiesKimberly M Komatsubara, Richard D CarvajalCancer Journal (Sudbury, Mass.)|March 29, 2012
Therapeutic implications of KIT in melanomaMichael A Postow, Richard D CarvajalCancer Treatment and Research|November 26, 2015
Treatment of Uveal MelanomaAlexander N Shoushtari, Richard D CarvajalHematology/Oncology Clinics of North America|June 2, 2014
Treatments for noncutaneous melanomaDanny N Khalil, Richard D CarvajalOncology (Williston Park, N.Y.)|September 25, 2018
Prognostic Value of Low Tumor Burden in Patients With MelanomaAndrew S Poklepovic, Richard D CarvajalCanadian Journal of Physiology and Pharmacology|June 1, 1991
Diabetes-induced rat hyposensitivity to compound 48/80A Casacó, D Carvajal, Z TolónPageof 22